切换导航
关闭
  • 菜单
  • Setting

Heparin sodium

肝素钠
Catalog No.
A5066
抗凝血酶III激活剂
组合的产品项目
规格价格库存 数量
100mg
¥ 381.00
现货
500mg
¥ 609.00
现货

电话: 021-55669583

邮箱: sales@apexbio.cn

全球经销商

A

背景

Minimum activity: > 150 I.U./mg. Glycosaminoglycan that behaves as an anticoagulant. Binds with high affinity to antithrombin III (AT-III).

文献引用

化学属性

Physical AppearanceA solid
StorageStore at -20°C
M.Wt50000
Cas No.9041-08-1
Solubilityinsoluble in EtOH; insoluble in DMSO; ≥12.75 mg/mL in H2O
运输条件 蓝冰运输或根据您的需求运输。
一般建议不同厂家不同批次产品溶解度各有差异,仅做参考。若实验所需浓度过大至产品溶解极限,请添加助溶剂助溶或自行调整浓度。溶液形式一般不宜长期储存,请尽快用完。

试验操作

Animal experiment:[1]

Animal models

Male New Zealand rabbits with a mean body weight of 2300 ± 300 g

Dosage form

2000 IU heparin

Administered by the intravenous route (i.v.)

Applications

Heparin increased both anti-factor Xa activity and activated partial thromboplastin time (aPTT). Heparin (2000 IU, i.v.) showed an AUC0→24/kg value of 3.30 ± 0.59 IU·h-1·mL-1·kg-1, with 100% absolute bioavailability. Apart from the parenteral route, heparin could also be administered by the oral route when incorporated into polymeric nanoparticles which were able to maintain the anti-Xa activity of heparin for a longer period.

Note

The technical data provided above is for reference only.

References:

1. Jiao Y, Ubrich N, Marchand-Arvier M, et al. In vitro and in vivo evaluation of oral heparin-loaded polymeric nanoparticles in rabbits. Circulation, 2002, 105(2): 230-235.

质量控制

质量控制和MSDS

批次: